Your browser doesn't support javascript.
loading
Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.
Gouda, Mohamed A; Zarzour, Maria A; Vaporciyan, Ara A; Kairemo, Kalevi; Chuang, Hubert H; Subbiah, Vivek.
Afiliación
  • Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zarzour MA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Vaporciyan AA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Kairemo K; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Chuang HH; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Subbiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Oncoscience ; 10: 44-53, 2023.
Article en En | MEDLINE | ID: mdl-37736255

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncoscience Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Oncoscience Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos